Skip to main content
Caplight Logo









OpenEvidence

OpenEvidence

Private
Miami, FloridaHealthcare & Life Scienceshttps://www.openevidence.com/

Last Round

Growth Equity

Jul 19, 2026

Est. Valuation

$20B

Total Funding Raised

$735M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

OpenEvidence is a healthcare technology company that develops an AI-powered medical search engine and clinical decision support platform for healthcare professionals.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Healthcare Analytics, Clinical Trials, Drug Discovery, NLP & Conversational AI

Business Model

B2B2C

Customer Profile

Data as a Service, Subscription SaaS

AI Layer

Application

Keywords

clinical decision supportmedical AIAI copilotevidence-based medicineclinical trial managementdrug discoveryhealthcare SaaScontinuing educationmedical literature synthesisEHR integrationphysician toolsAI healthcareclinical workflow automationmedical searchdoctor copilot

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OpenEvidence Comparables

Compare OpenEvidence with similar companies based on industry and business-model similarity.

OpenEvidence comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
athenahealth
79%
Doximity
78%
NoveList
77%

OpenEvidence Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityJul 19, 2026
Series DJan 21, 2026
Series COct 20, 2025
Series BJul 15, 2025
Series AFeb 19, 2025

Secondary Market Activity

Bids, offers, and trades by month

Data table
OperationDatePriceSizeShare ClassStructure
OFFER
BID
BID
OFFER
BID
OFFER

Key People

Founding team and executive leadership

James Phimister

Strategic Advisor To The CEO, National Health System Partnerships

Executive Team

Laurent Schockmel

Strategic advisor to the CEO

Executive Team

OpenEvidence Investors

Notable investors and investment history

OpenEvidence investors
InvestorRounds
Breyer CapitalSeries D
DST GlobalSeries D
BlackstoneSeries C, Series D
ICONIQ CapitalSeries D
GVSeries D, Series C, Series B
ConvictionSeries B, Series D
Craft VenturesSeries C, Series D

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 19, 2026

    $200M raised at $20B post-money valuation.

  • Jul 1, 2026

    Open job postings surged to 11 roles, 2.1x the trailing average.

OpenEvidence Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OpenEvidence Filings

SEC and related filings with document metadata.

Appears On

Curated lists and screens where this company is featured.

Frequently Asked Questions

Common questions about OpenEvidence's valuation, stock price, and market status.

Firmographic Details

HeadquartersMiami, Florida
Employee Range118
Year Founded2022
Last FundingJul 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?